MOH · Molina Healthcare, Inc.

Current Thesis

Managed-care trough-year rotation that has run its first leg and stalled. After Molina detonated on its Q4 2025 print (~2026-02-05) an adjusted loss of -$2.75/sh and a 2026 adjusted-EPS guide slashed to ≥$5.00 vs ~$13.71 consensus, stock -28% the Q1 2026 report (late April) stabilized the tape: adj EPS $2.35, consolidated MCR 91.1%, Medicaid MCR 92.0%, FY26 reaffirmed. The May 8 Investor Day then handed bulls a long-dated anchor: a $25 adjusted-EPS-by-2029 target with pretax margins expanding from <1% (2026) to ~2.5% (2029). But the easy mean-reversion is done. MOH closed $190.86 (2026-06-05), ~+58% off the $121.06 low, and has gone sideways for weeks with no momentum impulse. The tell that the rebound outran fundamentals: Morgan Stanley raised its PT to $167 (2026-06-04, Equal-Weight) and the consensus PT (~$172) still sits BELOW spot. This is a MATURING recovery in a chop zone, not an accelerating narrative LOW conviction with no fresh catalyst until the 2026-07-22 Q2 print.

Bull Case

• Q1 2026 stabilization (late Apr): adj EPS $2.35, consolidated MCR 91.1%, Medicaid MCR 92.0% management called medical-cost trend "moderately favorable" to plan; FY26 reaffirmed at ~$42B premium revenue / ≥$5.00 adj EPS.
• Investor Day long-ramp (2026-05-08): $25 adjusted EPS by 2029 target, pretax margin from <1% (2026) to ~2.5% (2029). If credible, the $5 trough is the bottom of a multi-year earnings ramp, not a new normal.
• Acuity mismatch fading: the ~250bps Medicaid acuity gap that wrecked 2025 is described as "largely diminished"; 2026 is built on a ~5% cost-trend assumption real trend below that makes the ≥$5.00 guide conservative.
• Rate catch-up cycle: 2026 is the called trough for Medicaid margins (sector underfunded ~300–400bps); rate filings catch up over 12–24 months (CMS +5.06% MA rate for 2026), supporting 2027–28 earnings well above $5.
• Valuation reset: ~39% below the $311.53 52-wk high; self-help via exiting the loss-making MA-PD product for 2027 ($93M Q1 impairment) removes a margin drag.

Bear Case

• Sell-side sees downside from here: consensus PT ~$172 vs $190.86 spot; Morgan Stanley's raised PT is still $167. Most analysts rate Hold the relief leg has priced ahead of the fundamentals.
• Medicaid MCR still elevated: a 92.0% Medicaid MCR (Q1 2026) is far above the high-80s that signals healthy margin; one quarter of "moderately favorable" trend does not prove durable cost control.
• ACA subsidy cliff: enhanced premium tax credits expired end-2025; Marketplace effectuated enrollment projected to fall from 22.3M (2025) to ~17.5M (2026, -25%), premiums up a median ~18% Molina's Marketplace book shrinks and adverse-selects into 2027.
• Membership bleed: post-H.R.1 Medicaid attrition (~6% flagged on the 2026 call) pressures revenue (Q1 premium rev ~-4% YoY).
• Optical valuation / credibility tax: GAAP P/E 53x (impairment-distorted); even on ≥$5.00 adj EPS that's ~38x forward on trough earnings. After the February guide-slash, any Q2 wobble re-opens the credibility discount.

Setup & Price Structure

• Close 2026-06-05: $190.86 (-1.0% on the day); market cap ~$9.94B; GAAP P/E 53.0.
• 52-wk range $121.06–$311.53 mid-range, ~39% below the high, ~+58% off the low.
• Structure is a post-capitulation recovery that has flattened: Feb gap-down to the lows → Q1-beat relief gap (late Apr) → multi-week consolidation $188–$192 with no follow-through. The momentum impulse has cooled to a drift, last two daily closes ticking lower.
• For a momentum book this is no-man's-land: thesis intact, but no accelerating leg to buy and no clean breakout trigger. Post-Q1 base support ~$165–170; a decisive break above ~$205–210 on a sector-cluster move would be the first sign the rotation is re-accelerating.

Catalyst Calendar (next 30 days)

• The next 30 days (2026-06-07 → 2026-07-07) are catalyst-light no scheduled binary. This is the dead patch between the Investor Day and the Q2 print.
• ~2026-06-30 (est.): ongoing summer state Medicaid rate-filing updates incremental, no single fixed date, but the tape watches for headline rate increases vs the ~5% cost-trend assumption.
• No fixed date: any ACA enhanced-subsidy extension legislation headline would be a re-rate trigger for the Marketplace book; none scheduled.
• 2026-07-22 (after close), call 2026-07-23 8:00 ET Q2 2026 print. The single binary: Medicaid MCR direction and whether FY26 ≥$5.00 holds. Sits just OUTSIDE the 30-day window; no fresh entry inside 3 trading days of it.
• Peer Q2 prints (UnitedHealth, Elevance, Centene) cluster ~late July and set sector tone also outside the 30-day window.

What Would Change Our Mind

• Turns constructive (re-rate to a tradeable leg): a decisive weekly close above ~$205–210 with managed-care peers breaking out together (cluster confirmation), OR a Q2 print (2026-07-22) showing Medicaid MCR rolling toward high-80s and FY26 guide raised above $5.00 — that flips this from MATURING drift to an accelerating cost-trend-normalization narrative worth sizing.
• any signals the cost trend is re-accelerating and the trough is not in.
• Neutral stall (stay LOW): continued $188–192 chop into July with consensus PT pinned below spot keeps this a probe-only watch, not an entry.

Correlation Notes

• Tightly correlated to the Medicaid-MCO complex Centene (CNC), Elevance (ELV), UnitedHealth (UNH). Sector cost-trend prints move these together; MOH is the highest-beta Medicaid-pure name, so it leads both up and down on cost-trend surprises.
• Policy-driven, not AI/macro-driven: the dominant exogenous variables are H.R.1 Medicaid attrition, ACA enhanced-subsidy expiry, and CMS/state rate filings largely uncorrelated to the AI/semiconductor momentum complex. Useful as a low-correlation diversifier, poor as a momentum vehicle.
• Rate-sensitive only second-order (investment income on float); the first-order driver is medical-cost ratio, a fundamental, not a rate trade.

Coda

The trough-year rotation is structurally sound for a 2027–28 normalization horizon, but that is a multi-quarter fundamental hold, not a momentum leg. Right now the narrative is MATURING, the sell-side PTs sit below spot, and the next binary is six-plus weeks out the kind of setup a momentum book sits out until either price clears ~$205–210 on cluster confirmation or the July 22 print re-fires the cost-trend story.

Cross-Reference

Track alongside the broader managed-care-rotation theme: confirmation requires the MCO complex (CNC/ELV/UNH) moving together, not MOH in isolation.